Search hospitals > Ohio > Akron
Cleveland Clinic Akron General
Claim this profileAkron, Ohio 44307
Global Leader in Breast Cancer
Global Leader in Breast cancer
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
Conducts research for Fallopian Tube Cancer
240 reported clinical trials
10 medical researchers
Summary
Cleveland Clinic Akron General is a medical facility located in Akron, Ohio. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Ovarian Cancer, Fallopian Tube Cancer and other specialties. Cleveland Clinic Akron General is involved with conducting 240 clinical trials across 279 conditions. There are 10 research doctors associated with this hospital, such as Kathryn M. Leininger, Esther H. Rehmus, Judy Peih-Ying Tsai, and Ashok Ramalingam.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Kathryn M. LeiningerCleveland Clinic Akron General5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
34 drugs studied
Esther H. RehmusCleveland Clinic Akron General11 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
12 reported clinical trials
28 drugs studied
Judy Peih-Ying TsaiCleveland Clinic Akron General5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
25 drugs studied
Ashok RamalingamCleveland Clinic Akron General9 years of reported clinical research
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
9 reported clinical trials
31 drugs studied
Clinical Trials running at Cleveland Clinic Akron General
Lung Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Bladder Cancer
Ovarian Cancer
Breast cancer
Small Cell Lung Cancer
Colorectal Cancer
Lymphoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cleveland Clinic Akron General?
Cleveland Clinic Akron General is a medical facility located in Akron, Ohio. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Ovarian Cancer, Fallopian Tube Cancer and other specialties. Cleveland Clinic Akron General is involved with conducting 240 clinical trials across 279 conditions. There are 10 research doctors associated with this hospital, such as Kathryn M. Leininger, Esther H. Rehmus, Judy Peih-Ying Tsai, and Ashok Ramalingam.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.